Gene Synergy Analysis via Data Discretization and Boolean Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional gene selection techniques using microarray analysis primarily focus on individual gene ranking based on correlation with diseases, failing to identify cooperative relationships or synergy among multiple interacting genes, which limits their effectiveness in developing therapeutic approaches.
Innovation Solution
The method involves analyzing gene expression data to identify cooperative interactions among multiple genes by discretizing the data, determining synergistic relationships using Boolean functions, and modeling these interactions to predict disease presence with high accuracy, employing a system with a processor and computer-readable medium to execute instructions for gene selection and synergy analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional individual gene ranking techniques are used, then classification between disease and health is convenient, but cooperative relationships and synergy among multiple interacting genes are not identified
Solution Approach 1:
The patent segments the analysis process into two distinct phases: first performing individual gene ranking for convenient classification, then conducting a second-stage analysis to identify cooperative relationships among top-ranked genes. This segmentation allows both classification convenience and discovery of gene interactions to be achieved at different stages of the analysis.
Solution Approach 2:
The patent transitions from one-dimensional individual gene analysis to two-dimensional analysis by examining not only individual gene expression levels but also the joint expression patterns and interactions between multiple genes. This dimensional expansion enables the detection of cooperative relationships while maintaining the benefits of individual gene ranking.
2Measurement precision
If individual gene ranking based on correlation is used, then genes with clear separation between diseased and healthy tissues are identified, but the cooperative nature of gene contributions towards phenotype is not analyzed
Solution Approach 1:
The patent performs preliminary individual gene ranking and identification of genes with clear expression separation before conducting the analysis of cooperative relationships. This preliminary action establishes a foundation of high-quality candidate genes that exhibit strong disease association, which then serves as the basis for subsequent interaction analysis.
Solution Approach 2:
The patent implements a nested analysis structure where individual gene ranking results are nested within a broader cooperative interaction analysis framework. The individually ranked genes form the inner layer, while the analysis of their joint relationships and synergistic effects forms the outer layer, allowing both types of analysis to be integrated.
3Productivity
If traditional gene selection techniques are used, then a list of correlated genes is produced, but insight into therapeutic approach development is limited
Solution Approach 1:
The patent maintains continuous useful action by seamlessly transitioning from rapid gene selection to deeper interaction analysis without breaking the analytical workflow. The method continuously processes gene data through multiple analytical stages, from initial ranking to cooperative relationship identification, maximizing the therapeutic insight potential throughout the entire analysis process.
Data Source
AI summary
A method is provided for selecting two or more genes from gene expression data. In the method, gene expression data for a plurality of genes is provided, where the gene expression data include expression levels for each of the plurality of genes. The gene expression data is discretized. Based on the discretized gene expression data, the synergy among the plurality of genes with respect to a phenotype, for example, presence or absence of a disease in a tissue, is evaluated. Two or more genes whose synergy exceeds a predetermined threshold are selected. A system implementing the method is also provided.